Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

Pedigree Analysis

Pedigree Analysis

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advances in CSF1R-related disorder: novel mutations, dopaminergic imaging, and overcoming underdiagnosis.

Neurologia i neurochirurgia polska·2026

Same author

Discovery of a mutation-containing circRNA in polyglutamine disease through systematic analysis of RNAs with CAG repeats.

RNA biology·2026

Same author

Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications.

International journal of laboratory hematology·2026

Same author

HeyJay! A corpus of atypical speech for spoken language understanding and automatic speech recognition.

Scientific data·2026

Same author

Reply to "Clinical-Imaging Discordance in Suspected Osteoid Osteoma: Importance of Targeted CT Evaluation".

International journal of surgical pathology·2026

Same author

Frontotemporal lobar degeneration-TDP mimicking progressive supranuclear palsy: A perspective on clinicopathology, genetics, and biomarkers.

Neural regeneration research·2026

Search research articles

Related Experiment Video

Updated: Jul 22, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Perry Disease: Expanding the Genetic Basis.

Jarosław Dulski^1,2,3, Shunsuke Koga⁴, Paweł P Liberski^5,6

¹Department of Neurology Mayo Clinic Jacksonville Florida USA.

Movement Disorders Clinical Practice

|July 21, 2023

Summary

Perry disease, a fatal neurodegenerative disorder, is linked to novel DCTN1 gene mutations outside the typical CAP-Gly domain. This study details the first clinicopathological findings of such a case.

Keywords:

DCTN1 TDP‐43 hypoventilation parkinsonism weight loss

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Jul 22, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

Area of Science:

Genetics
Neuroscience
Pathology

Background:

Perry disease (PS) is a fatal, hereditary neurodegenerative disorder.
Previously confirmed PS cases involved mutations in the CAP-Gly domain of the DCTN1 gene.

Purpose of the Study:

To report the first clinicopathological case of Perry disease caused by a novel DCTN1 mutation outside the CAP-Gly domain.
To compare the clinical and pathological features of this new variant with previously reported cases.

Main Methods:

Clinicopathological examination of a novel Perry disease case.
Genetic analysis to identify DCTN1 mutation.
Comparative analysis with existing Perry disease case reports.

Main Results:

Identification of a novel pathogenic DCTN1 mutation outside the CAP-Gly domain in a Perry disease patient.
Detailed clinical and autopsy findings of the affected individual.
Comparison highlighting similarities and differences with known Perry disease variants.

Conclusions:

The DCTN1 gene is implicated in Perry disease beyond the CAP-Gly domain.
This finding expands the genetic understanding of Perry disease.
Further research into DCTN1 mutations is warranted for Perry disease diagnosis and treatment.